Skip to content

Clinical trials

Phase 2 Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 2 Country / region: United States Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20026
20032
20057
200614
20073
20086
20095
20106
20114
20121
20142
20155
20161
20174
20183
20194
20206
20213
20228
20236
20246
20255
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Recruiting22
Terminated14
Active, not recruiting11
Withdrawn4
Not yet recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
Eli Lilly and Company6
National Cancer Institute (NCI)6
Pfizer5
H. Lee Moffitt Cancer Center and Research Institute4
AstraZeneca3
M.D. Anderson Cancer Center3
Oncolytics Biotech3
Sunesis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma117
Neoplasms39
Carcinoma, Non-Small-Cell Lung20
Neoplasm Metastasis19
Adenocarcinoma16
Squamous Cell Carcinoma of Head and Neck13
Head and Neck Neoplasms11
Mouth Neoplasms11
Laryngeal Neoplasms10
Lung Neoplasms9

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.